Evaluating the effect of a simple cooling cap in heat-sensitive people

Other measures (1)

Background and study aims Multiple sclerosis (MS) is a condition that can affect the brain and spinal cord, causing a wide range of potential symptoms, including problems with vision, arm or leg movement, sensation or balance. Heat sensitivity is a common symptom in MS. Symptom deterioration usually appears after 8 minutes of heating, when the body temperature has increased by 0.8°C, and is reduced approximately after 15 minutes after heating is ended. Especially during the hot summer months, an increase in body temperature can cause difficulties in normal daily functioning in people with multiple sclerosis. In previous studies, different techniques and equipment have been used to provide cooling. Active cooling techniques (usually a vest or other liquid condition garment) achieve a greater effect than passive ones. The main limitations of these garments are the lack of transportability and large power source. Other options represent cooling techniques based on the principle of evaporation. In most cases, cooling the centre of the body, i.e. the torso area, is achieved with various types of vests. In clinical practice, we sometimes meet patients who have had a positive experience with simple cooling devices based on the principle of evaporation (manufactured, for example, for athletes or motorcyclists). The aim of this study was therefore to verify whether these simple and cheap cooling aids can really affect functional performance in thermosensitive people with MS. Who can participate? People with multiple sclerosis who are thermosensitive (they feel worsening of their symptoms during hot days). What does the study involve? It is necessary to visit the rehabilitation centre on 2 different days to receive a cooling cap and undergo functional assessment (walking tests, fine motoric skills and questionnaire). What are the possible benefits and risks of participating? The benefit of participating in the study is receiving a cooling cap. There are no risks associated with participation in the study. Where is the study run from? Department of Neurology First Faculty of Medicine and General University Hospital (Czechia) When is the study starting and how long is it expected to run for? September 2016 to December 2020 Who is funding the study? MS rehab z.s. (Czechia) Who is the main contact? Klara Novotna, klara.novotna@vfn.cz